Literature DB >> 17237602

Immunostimulatory flagellin from Burkholderia pseudomallei effects on an increase in the intracellular calcium concentration and up-regulation of TNF-alpha by mononuclear cells.

Ya-Lei Chen1, Yao-Shen Chen, Hsi-Hsun Lin, Chun-Wen Chan, Ssu-Ching Chen, Ching-Hsein Chen.   

Abstract

Using flow cytometry analysis, the flagellin of Burkholderia pseudomallei acts as a signalling inducer, and evokes an increase in the intracellular calcium ion concentration ([Ca(2+)]i) in human peripheral blood mononuclear cells (PBMC). The cells with increased [Ca(2+)]i segregate into the live monocyte gate and not into the live lymphocyte gates. The stimulated [Ca(2+)]i increase can be neutralized with anti-flagellin antibodies. In the absence of [Ca(2+)], [Ca(2+)]i was increased rapidly in flagellin-treated cells compared to non-flagellin-treated cells only after the addition of 1 mM CaCl(2). Selective calcium antagonists were used to effectively block the [Ca(2+)]i signal, revealing that this signal was decreased by the addition of L-type calcium channel blockers (diltiazem, nifedipine and verapamil) and La(2+) but was not changed by the addition of a T-type calcium channel blocker (flunarizine). It seemed that flagellin facilitates [Ca(2+)]i influx via a La(2+) sensitive L-type cellular membrane channel. Furthermore, flagellin also acts as a TNF-alpha inducer in a time- and concentration-dependent manner when adhered mononuclear cells are treated with flagellin. This ability to induce TNF-alpha production was affected by the presence of [Ca(2+)] in the culture medium. It suggested that B. pseudomallei flagellin is an immuno-stimulatory molecule, causing an increase in [Ca(2+)]i and an up-regulation of TNF-alpha, which may play an important role in the inflammation process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237602     DOI: 10.1111/j.1348-0421.2007.tb03893.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  7 in total

1.  Chronic Calcium Channel Inhibitor Verapamil Antagonizes TNF-α-Mediated Inflammatory Reaction and Protects Against Inflammatory Arthritis in Mice.

Authors:  Wenhan Wang; Zhong Li; Qingjuan Meng; Pei Zhang; Pengcheng Yan; Zhenbiao Zhang; Hao Zhang; Jingrui Pan; Yujia Zhai; Yaoge Liu; Xiaokai Wang; Weiwei Li; Yunpeng Zhao
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

2.  Role of Toll-Like Receptor 5 (TLR5) in Experimental Melioidosis.

Authors:  Emma Birnie; Tassili A F Weehuizen; Jacqueline M Lankelma; Hanna K de Jong; Gavin C K W Koh; Miriam H P van Lieshout; Joris J T H Roelofs; Andries E Budding; Alex F de Vos; Tom van der Poll; W Joost Wiersinga
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  Enterobacter cloacae: a villain in CaOx stone disease?

Authors:  Yuanyuan Yang; Senyuan Hong; Jinzhou Xu; Cong Li; Shaogang Wang; Yang Xun
Journal:  Urolithiasis       Date:  2022-02-06       Impact factor: 3.436

4.  Combination use of immune complexes and a Ca2(+) channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells.

Authors:  T Abe; I Fuse; M Narita; M Takahashi; Y Aizawa
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

5.  MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216.

Authors:  Joannes A A Reijers; D G Kallend; K E Malone; J W Jukema; P L J Wijngaard; J Burggraaf; M Moerland
Journal:  Cardiovasc Drugs Ther       Date:  2017-08       Impact factor: 3.727

Review 6.  An Evolutionary Arms Race Between Burkholderia pseudomallei and Host Immune System: What Do We Know?

Authors:  Chalita Chomkatekaew; Phumrapee Boonklang; Apiwat Sangphukieo; Claire Chewapreecha
Journal:  Front Microbiol       Date:  2021-01-21       Impact factor: 5.640

7.  Immune response to recombinant Burkholderia pseudomallei FliC.

Authors:  Sirikamon Koosakulnirand; Phornpun Phokrai; Kemajittra Jenjaroen; Rosemary A Roberts; Pongsak Utaisincharoen; Susanna J Dunachie; Paul J Brett; Mary N Burtnick; Narisara Chantratita
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.